Malcolm Reeves: There's a number I want to start with. Twenty-three.
Cole Brennan: Hit me.
Malcolm Reeves: Twenty-three percent of one standard deviation. That's how much biologically older people born between 1965 and 1974 are — compared to people born 1950 to 1954 — at the same chronological age. Washington University School of Medicine published it in Nature Medicine, June 22nd, 2026. Lead researcher is Yin Cao, molecular epidemiologist. And the sample isn't small — 154,169 adults in the UK Biobank, corroborated by over 10,000 in the NIH All of Us Research Program.
Cole Brennan: Wait — so we're not talking about one unlucky generation. This is a cohort-wide shift.
Malcolm Reeves: Systemic. And it connects to cancer risk — an 8 to 15 percent higher chance of early-onset solid cancers. Diagnosed at 55 or younger.
Cole Brennan: For real. And the metric they're using — PhenoAge — that's not like, a vibe check. That's nine blood biomarkers run through an algorithm. The age gap between what your blood says and what your birthday says. That's the thing Yin Cao's team is measuring across generations.
Malcolm Reeves: Now — and I want to flag this early — the pattern is documented. The cause is not. Those are two different things, and the study doesn't conflate them.
Malcolm Reeves: Think of it like a car. Model year versus mileage. Two vehicles roll off the line in 1970, same make, same model — one's got forty thousand miles on it, one's got a hundred and eighty thousand. The birth certificate is the model year. PhenoAge is the odometer.
Cole Brennan: That's — yeah. That clicks.
Malcolm Reeves: And what's new — genuinely new, not just 'people are aging faster' in some headline sense — is the tissue-specific piece. Because the study doesn't just say the body is wearing out. It says *which part* wears out tells you *what* will likely go wrong. Immune system aging tracks with earlier lung cancer. Fat tissue aging tracks with earlier colorectal cancer. Those are different organs aging at different speeds inside the same person.
Cole Brennan: Hold on — so it's not one uniform biological clock ticking faster. Different tissues have their own rate.
Malcolm Reeves: That's the signal. And there's more — PhenoAgeAccel, the actual acceleration score, has also been linked to metabolic dysfunction-associated fatty liver disease and carotid atherosclerosis. So this isn't only a cancer story, and I think that's where the headline undersells it.
Cole Brennan: Right, like — fatty liver, cardiovascular disease, cancer. That's not one system misfiring, that's... I mean, it's kind of everywhere at once. Which is what makes PhenoAge actually useful, I think — it's pulling from nine blood markers, it's cross-system by design.
Malcolm Reeves: But here's what I want to push back on — the read that's already spreading. That this is individual failure. That the 1965-to-1974 cohort just... made worse choices.
Cole Brennan: Yeah, the 'young people don't take care of themselves' thing.
Malcolm Reeves: That cohort didn't choose industrial agriculture at full stride, or sedentary office work becoming the norm, or ultra-processed food hitting scale right when they were growing up. They inherited that system. Every single one of them. And I think the study — even without naming the cause, which it explicitly doesn't — the pattern points structurally, not individually.
Cole Brennan: Okay, but — wait, actually that's where I want to press. Because the physical cause is genuinely unconfirmed. Like, Nature Medicine says correlation, not mechanism. So... are we pattern-matching too fast? What if it's something more invisible — microplastics, chronic low-grade stress — and lifestyle is just riding alongside it?
Malcolm Reeves: That's a fair challenge. And the study doesn't close it. But here's what makes the picture stranger — a 40-year-old today probably looks younger than a 40-year-old in the 1980s. Better skin, gym access, the whole thing. The cosmetic inversion. We've optimized for appearing well while the internal biological profile deteriorates faster.
Cole Brennan: Man. That's — that's genuinely unsettling. So the entire wellness industry might be... aimed at the wrong target?
Cole Brennan: And then there's this — the bariatric surgery study. 505 patients, published in npj Aging, 2026. Biological age acceleration dropped by 5.55 years. In twelve months. That's not a nudge, that's — I mean, that's a reversal. It keeps hitting me because it means the damage isn't locked in. It's tractable. Which is wild. But also —
Malcolm Reeves: But that's one surgery. One person, one metabolic intervention, one year. The cohort data — the UK Biobank, 154,000 people — that's moving the other direction. And it keeps moving. So you've got these two curves going opposite ways at the same time.
Cole Brennan: Right, which is — okay, that's the question that won't leave me alone. If you can reverse it individually, but entire birth cohorts keep accelerating, are we just... getting really good at helping people escape a burning building while the building keeps burning?
